Overview
Veda Giri is an Oncologist in New Haven, Connecticut. Dr. Giri is rated as an Experienced provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Lynch Syndrome, and Upper Tract Urothelial Carcinoma (UTUC).
Her clinical research consists of co-authoring 86 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of BRCA Positive Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
35 Park St, New Haven, CT 06519
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Julie Gold is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer.
WPHPA Cancer And Blood Specialists Of New York
Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Osteosarcoma, Chondrosarcoma, and Angiosarcoma.
Hartford Hospital
Daniel Morganstern is a Hematologist Oncology specialist and a Hematologist in Manchester, Connecticut. Dr. Morganstern is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Giri isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Giri isDistinguished. Learn about Prostate Cancer.
- Experienced
- BRCA Positive Breast CancerDr. Giri isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast CancerDr. Giri isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Giri isExperienced. Learn about Breast Cancer in Men.
- Chromophobe Renal Cell CarcinomaDr. Giri isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Giri isExperienced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Giri isExperienced. Learn about Familial Wilms Tumor 2.